In addition, IDO1 is also upregulated in cancer-associated immune cells, such as dendritic cells and macrophages, which promotes immune evasion by depleting tryptophan in the tumor microenvironment, particularly at the immunological synapse (Meireson et al., 2020). This evidence concerns the gene IDO1 and cancer.